Skip to main content
. 2021 Mar 11;13(3):904. doi: 10.3390/nu13030904

Figure 2.

Figure 2

Effect of acute oral administration of Safr’InsideTM (6.25 and 600 mg/Kg) on depressive-like behavior measured in the FST. (a) Immobility time; (b) Index of immobility. FST has been conducted 30 min after gavage. Results are shown as mean ± SEM. Control (Water): n = 9; Safr’Inside (6.25 mg/Kg): n = 10; Safr’Inside (600 mg/Kg): n = 9. * p < 0.05.